help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, T. R.
Right arrow Articles by Matzuk, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, T. R.
Right arrow Articles by Matzuk, M. M.
Molecular Endocrinology 13 (6): 851-865
Copyright © 1999 by The Endocrine Society

Transgenic Models to Study Gonadotropin Function: The Role of Follicle-Stimulating Hormone in Gonadal Growth and Tumorigenesis

T. Rajendra Kumar, Ganesh Palapattu, Pei Wang, Teresa K. Woodruff, Irving Boime, Michael C. Byrne and Martin M. Matzuk

Department of Pathology (T.R.K., G.P., P.W., M.M.M) Department of Cell Biology (M.M.M.) Department of Molecular and Human Genetics (M.M.M.) Baylor College of Medicine Houston, Texas 77030
Department of Medicine and Neurobiology and Physiology (T.K.W.) Northwestern University Chicago, Illinois 60611
Department of Molecular Biology and Pharmacology (I.B.) Washington University School of Medicine St. Louis, Missouri 63110
Genetics Institute (M.C.B.) Cambridge, Massachusetts 02140

The role of FSH in gonadal tumorigenesis and, in particular, in human ovarian cancer has been debated. It is also unclear what role the elevated FSH levels in the inhibin-deficient mouse play in the gonadal tumorigenesis. To directly assess the role of FSH in gonadal growth, differentiation, and gonadal tumorigenesis, we have generated both gain-of-function and loss-of-function transgenic mutant mice. In the gain-of-function model, we have generated transgenic mice that ectopically overexpress human FSH from multiple tissues using a mouse metallothionein-1 promoter, achieving levels far exceeding those seen in postmenopausal women. Male transgenic mice are infertile despite normal testicular development and demonstrate enlarged seminal vesicles secondary to elevated serum testosterone levels. Female transgenic mice develop highly hemorrhagic and cystic ovaries, have elevated serum estradiol and progesterone levels, and are infertile, mimicking the features of human ovarian hyperstimulation and polycystic ovarian syndromes. Furthermore, the female transgenic mice develop enlarged and cystic kidneys and die between 6–13 weeks as a result of urinary bladder obstruction. In a complementary loss-of-function approach, we have generated double-homozygous mutant mice that lack both inhibin and FSH by a genetic intercross. In contrast to male mice lacking inhibin alone, 95% of which die of a cancer cachexia-like syndrome by 12 weeks of age, only 30% of the double-mutant male mice lacking both FSH and inhibin die by 1 yr of age. The remaining double-mutant male mice develop slow-growing and less hemorrhagic testicular tumors, which are noted after 12 weeks of age, and have minimal cachexia. Similarly, the double-mutant female mice develop slow-growing, less hemorrhagic ovarian tumors, and 70% of these mice live beyond 17 weeks. The double-mutant mice demonstrate minimal cachexia in contrast to female mice lacking only inhibin, which develop highly hemorrhagic ovarian tumors, leading to cachexia and death by 17 weeks of age in 95% of the cases. The milder cachexia-like symptoms of the inhibin and FSH double-mutant mice are correlated with low levels of serum estradiol and activin A and reduced levels of aromatase mRNA in the gonadal tumors. Based on these and our previous genetic analyses, we conclude that elevated FSH levels do not directly cause gonadal tumors. However, these results suggest FSH is an important trophic modifier factor for gonadal tumorigenesis in inhibin-deficient mice.




This article has been cited by other articles:


Home page
 FASEB J.Home page
S. A. Williams and P. Stanley
Mouse fertility is enhanced by oocyte-specific loss of core 1-derived O-glycans
FASEB J, July 1, 2008; 22(7): 2273 - 2284.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. P. Purdue, B. I. Graubard, S. J. Chanock, M. V. Rubertone, R. L. Erickson, and K. A. McGlynn
Genetic Variation in the Inhibin Pathway and Risk of Testicular Germ Cell Tumors
Cancer Res., April 15, 2008; 68(8): 3043 - 3048.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Q. Li, J. M. Graff, A. E. O'Connor, K. L. Loveland, and M. M. Matzuk
SMAD3 Regulates Gonadal Tumorigenesis
Mol. Endocrinol., October 1, 2007; 21(10): 2472 - 2486.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. A. Pangas, C. J. Jorgez, M. Tran, J. Agno, X. Li, C. W. Brown, T. R. Kumar, and M. M. Matzuk
Intraovarian Activins Are Required for Female Fertility
Mol. Endocrinol., October 1, 2007; 21(10): 2458 - 2471.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
B. D. Looyenga and G. D. Hammer
Genetic Removal of Smad3 from Inhibin-Null Mice Attenuates Tumor Progression by Uncoupling Extracellular Mitogenic Signals from the Cell Cycle Machinery
Mol. Endocrinol., October 1, 2007; 21(10): 2440 - 2457.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. J. McTavish, M. Jimenez, K. A. Walters, J. Spaliviero, N. P. Groome, A. P. Themmen, J. A. Visser, D. J. Handelsman, and C. M. Allan
Rising Follicle-Stimulating Hormone Levels with Age Accelerate Female Reproductive Failure
Endocrinology, September 1, 2007; 148(9): 4432 - 4439.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
Q. Li, R. Kumar, K. Underwood, A. E. O'Connor, K. L. Loveland, J. S. Seehra, and M. M. Matzuk
Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein
Mol. Hum. Reprod., September 1, 2007; 13(9): 675 - 683.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. R. Kumar
Multiple Ovulations, Ovarian Epithelial Inclusion Cysts, and It'SMAD Two!
Endocrinology, August 1, 2007; 148(8): 3591 - 3594.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Andreu-Vieyra, R. Chen, and M. M. Matzuk
Effects of Granulosa Cell-Specific Deletion of Rb in Inha-{alpha} Null Female Mice
Endocrinology, August 1, 2007; 148(8): 3837 - 3849.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J.-H. Choi, A. S. T. Wong, H.-F. Huang, and P. C. K. Leung
Gonadotropins and Ovarian Cancer
Endocr. Rev., June 1, 2007; 28(4): 440 - 461.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
JJ. Ireland, F. Ward, F. Jimenez-Krassel, J.L.H. Ireland, G.W. Smith, P. Lonergan, and A.C.O. Evans
Follicle numbers are highly repeatable within individual animals but are inversely correlated with FSH concentrations and the proportion of good-quality embryos after ovarian stimulation in cattle
Hum. Reprod., June 1, 2007; 22(6): 1687 - 1695.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
B. D. Looyenga and G. D. Hammer
Origin and Identity of Adrenocortical Tumors in Inhibin Knockout Mice: Implications for Cellular Plasticity in the Adrenal Cortex
Mol. Endocrinol., November 1, 2006; 20(11): 2848 - 2863.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
K.R. Barnett, C. Schilling, C.R. Greenfeld, D. Tomic, and J.A. Flaws
Ovarian follicle development and transgenic mouse models
Hum. Reprod. Update, September 1, 2006; 12(5): 537 - 555.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C M Allan, Y Wang, M Jimenez, B Marshan, J Spaliviero, P Illingworth, and D J Handelsman
Follicle-stimulating hormone increases primordial follicle reserve in mature female hypogonadal mice.
J. Endocrinol., March 1, 2006; 188(3): 549 - 557.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
C. J. Guigon and S. Magre
Contribution of Germ Cells to the Differentiation and Maturation of the Ovary: Insights from Models of Germ Cell Depletion
Biol Reprod, March 1, 2006; 74(3): 450 - 458.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
P. Su, J. C. Wu, J. R. Sommer, A. J. Gore, R. M. Petters, and W. L. Miller
Conditional Induction of Ovulation in Mice
Biol Reprod, October 1, 2005; 73(4): 681 - 687.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
S. B Rulli and I. Huhtaniemi
What have gonadotrophin overexpressing transgenic mice taught us about gonadal function?
Reproduction, September 1, 2005; 130(3): 283 - 291.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
W. H Walker and J. Cheng
FSH and testosterone signaling in Sertoli cells
Reproduction, July 1, 2005; 130(1): 15 - 28.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Young, P. Chanson, S. Salenave, M. Noel, S. Brailly, M. O'Flaherty, G. Schaison, and R. Rey
Testicular Anti-Mullerian Hormone Secretion Is Stimulated by Recombinant Human FSH in Patients with Congenital Hypogonadotropic Hypogonadism
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 724 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
M. Jimenez, J.A. Spaliviero, A.J. Grootenhuis, J. Verhagen, C.M. Allan, and D.J. Handelsman
Validation of an Ultrasensitive and Specific Immunofluorometric Assay for Mouse Follicle-Stimulating Hormone
Biol Reprod, January 1, 2005; 72(1): 78 - 85.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X. Ma, Y. Dong, M. M. Matzuk, and T. R. Kumar
Targeted disruption of luteinizing hormone {beta}-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility
PNAS, December 7, 2004; 101(49): 17294 - 17299.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. J. Jorgez, M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk
Granulosa Cell-Specific Inactivation of Follistatin Causes Female Fertility Defects
Mol. Endocrinol., April 1, 2004; 18(4): 953 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. H. Burns, J. E. Agno, P. Sicinski, and M. M. Matzuk
Cyclin D2 and p27 Are Tissue-Specific Regulators of Tumorigenesis in Inhibin {alpha} Knockout Mice
Mol. Endocrinol., October 1, 2003; 17(10): 2053 - 2069.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. H. Burns, J. E. Agno, L. Chen, B. Haupt, S. C. Ogbonna, K. S. Korach, and M. M. Matzuk
Sexually Dimorphic Roles of Steroid Hormone Receptor Signaling in Gonadal Tumorigenesis
Mol. Endocrinol., October 1, 2003; 17(10): 2039 - 2052.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. H. Burns, G. E. Owens, S. C. Ogbonna, J. H. Nilson, and M. M. Matzuk
Expression Profiling Analyses of Gonadotropin Responses and Tumor Development in the Absence of Inhibins
Endocrinology, October 1, 2003; 144(10): 4492 - 4507.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
M. M. Matzuk, F. J. DeMayo, L. A. Hadsell, and T. R. Kumar
Overexpression of Human Chorionic Gonadotropin Causes Multiple Reproductive Defects in Transgenic Mice
Biol Reprod, July 1, 2003; 69(1): 338 - 346.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
F. Beuschlein, B. D. Looyenga, S. E. Bleasdale, C. Mutch, D. L. Bavers, A. F. Parlow, J. H. Nilson, and G. D. Hammer
Activin Induces x-Zone Apoptosis That Inhibits Luteinizing Hormone-Dependent Adrenocortical Tumor Formation in Inhibin-Deficient Mice
Mol. Cell. Biol., June 1, 2003; 23(11): 3951 - 3964.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Haywood, J. Spaliviero, M. Jimemez, N. J. C. King, D. J. Handelsman, and C. M. Allan
Sertoli and Germ Cell Development in Hypogonadal (hpg) Mice Expressing Transgenic Follicle-Stimulating Hormone Alone or in Combination with Testosterone
Endocrinology, February 1, 2003; 144(2): 509 - 517.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
R. J. Mann, R. A. Keri, and J. H. Nilson
Consequences of Elevated Luteinizing Hormone on Diverse Physiological Systems: Use of the LH{beta}CTP Transgenic Mouse as a Model of Ovarian Hyperstimulation-induced Pathophysiology
Recent Prog. Horm. Res., January 1, 2003; 58(1): 343 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. A. Anderson and D. T. Baird
Male Contraception
Endocr. Rev., December 1, 2002; 23(6): 735 - 762.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Haywood, N. Tymchenko, J. Spaliviero, A. Koch, M. Jimenez, J. Gromoll, M. Simoni, V. Nordhoff, D. J. Handelsman, and C. M. Allan
An Activated Human Follicle-Stimulating Hormone (FSH) Receptor Stimulates FSH-Like Activity in Gonadotropin-Deficient Transgenic Mice
Mol. Endocrinol., November 1, 2002; 16(11): 2582 - 2591.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. B. Rulli, A. Kuorelahti, O. Karaer, L. J. Pelliniemi, M. Poutanen, and I. Huhtaniemi
Reproductive Disturbances, Pituitary Lactotrope Adenomas, and Mammary Gland Tumors in Transgenic Female Mice Producing High Levels of Human Chorionic Gonadotropin
Endocrinology, October 1, 2002; 143(10): 4084 - 4095.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. H. Burns and M. M. Matzuk
Minireview: Genetic Models for the Study of Gonadotropin Actions
Endocrinology, August 1, 2002; 143(8): 2823 - 2835.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. M. Zakaria, K.-H. Jeong, C. Lacza, and U. B. Kaiser
Pituitary Homeobox 1 Activates the Rat FSH{beta} (rFSH{beta}) Gene through Both Direct and Indirect Interactions with the rFSH{beta} Gene Promoter
Mol. Endocrinol., August 1, 2002; 16(8): 1840 - 1852.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
N. Danilovich, D. Javeshghani, W. Xing, and M. R. Sairam
Endocrine Alterations and Signaling Changes Associated with Declining Ovarian Function and Advanced Biological Aging in Follicle-Stimulating Hormone Receptor Haploinsufficient Mice
Biol Reprod, August 1, 2002; 67(2): 370 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
W. Xing and M. R. Sairam
Retinoic Acid Mediates Transcriptional Repression of Ovine Follicle-Stimulating Hormone Receptor Gene via a Pleiotropic Nuclear Receptor Response Element
Biol Reprod, July 1, 2002; 67(1): 204 - 211.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
G. E. Owens, R. A. Keri, and J. H. Nilson
Ovulatory Surges of Human CG Prevent Hormone-Induced Granulosa Cell Tumor Formation Leading to the Identification of Tumor-Associated Changes in the Transcriptome
Mol. Endocrinol., June 1, 2002; 16(6): 1230 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Varghese, A. D. Gagliardi, P. E. Bialek, S.-P. Yee, G. F. Wagner, and G. E. Dimattia
Overexpression of Human Stanniocalcin Affects Growth and Reproduction in Transgenic Mice
Endocrinology, March 1, 2002; 143(3): 868 - 876.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. J. Fuller, E. T. Zumpe, S. Chu, P. Mamers, and H. G. Burger
Inhibin-Activin Receptor Subunit Gene Expression in Ovarian Tumors
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1395 - 1401.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. P. Risbridger, J. F. Schmitt, and D. M. Robertson
Activins and Inhibins in Endocrine and Other Tumors
Endocr. Rev., December 1, 2001; 22(6): 836 - 858.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
W. Xing and M. R. Sairam
Role of CACC-Box in the Regulation of Ovine Follicle-Stimulating Hormone Receptor Expression
Biol Reprod, October 1, 2001; 65(4): 1142 - 1149.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. R. Kumar, S. Varani, N. G. Wreford, N. M. Telfer, D. M. de Kretser, and M. M. Matzuk
Male Reproductive Phenotypes in Double Mutant Mice Lacking Both FSH{beta} and Activin Receptor IIA
Endocrinology, August 1, 2001; 142(8): 3512 - 3518.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Danilovich, I. Roy, and M. R. Sairam
Ovarian Pathology and High Incidence of Sex Cord Tumors in Follitropin Receptor Knockout (FORKO) Mice
Endocrinology, August 1, 2001; 142(8): 3673 - 3684.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. C. Cipriano, L. Chen, K. H. Burns, A. Koff, and M. M. Matzuk
Inhibin and p27 Interact to Regulate Gonadal Tumorigenesis
Mol. Endocrinol., June 1, 2001; 15(6): 985 - 996.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. Huhtaniemi and A. Bartke
Perspective: Male Reproduction
Endocrinology, June 1, 2001; 142(6): 2178 - 2183.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
C. M. Allan, M. Haywood, S. Swaraj, J. Spaliviero, A. Koch, M. Jimenez, M. Poutanen, J. Levallet, I. Huhtaniemi, P. Illingworth, et al.
A Novel Transgenic Model to Characterize the Specific Effects of Follicle-Stimulating Hormone on Gonadal Physiology in the Absence of Luteinizing Hormone Actions
Endocrinology, June 1, 2001; 142(6): 2213 - 2220.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
X. Guo, P. L. Morris, and L. J. Gudas
Follicle-Stimulating Hormone and Leukemia Inhibitory Factor Regulate Sertoli Cell Retinol Metabolism
Endocrinology, March 1, 2001; 142(3): 1024 - 1032.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
C. Yan and M. M. Matzuk
Transgenic Models of Ovarian Failure
Reproductive Sciences, January 1, 2001; 8(1_suppl): S30 - S33.
[Abstract] [PDF]

Home page
 Endocr. Rev.Home page
A. P. N. Themmen and I. T. Huhtaniemi
Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function
Endocr. Rev., October 1, 2000; 21(5): 551 - 583.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
S. C. Cipriano, L. Chen, T. R. Kumar, and M. M. Matzuk
Follistatin Is a Modulator of Gonadal Tumor Progression and the Activin-Induced Wasting Syndrome in Inhibin-Deficient Mice
Endocrinology, July 1, 2000; 141(7): 2319 - 2327.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society